Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 256–270 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5022 RPS6KA3 Gene Mental Retardation, X-Linked Type 19 Genetic Test This genetic test identifies pathogenic mutations in the RPS6KA3 gene, which are associated with X-linked intellectual disability type 19.	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the RPS6KA3 gene"] Parameters [] Preparation [] Indications ["Suspected X-linked intellectual disability type 19", "Confirmation of molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: F79 Clinical summary This genetic test identifies pathogenic mutations in the RPS6KA3 gene, which are associated with X-linked intellectual disability type 19.
TEST-5529 RSPH9 Gene (Primary Ciliary Dyskinesia Type 12) Genetic Test This genetic test identifies pathogenic variants in the RSPH9 gene, confirming a diagnosis of Primary Ciliary Dyskinesia Type 12.	Peripheral whole blood	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RSPH9 gene", "Ciliary function impairment"] Parameters [] Preparation ["No special preparation required"] Indications ["Suspected Primary Ciliary Dyskinesia Type 12", "Chronic respiratory infections", "Family history of PCD"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q34.8 Clinical summary This genetic test identifies pathogenic variants in the RSPH9 gene, confirming a diagnosis of Primary Ciliary Dyskinesia Type 12.
TEST-2226 SALL1 Gene Townes-Brocks Syndrome Genetic Test This genetic test evaluates the SALL1 gene for pathogenic variants associated with Townes-Brocks syndrome.	Whole Blood (EDTA) or Extracted DNA	14–21 Business Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SALL1 gene"] Parameters [] Preparation [] Indications ["Suspected Townes-Brocks syndrome", "Congenital anomalies affecting multiple systems"] Measurement technique Confirm with laboratory Codes LOINC: 92104-8 ICD-10: Q87.8 Clinical summary This genetic test evaluates the SALL1 gene for pathogenic variants associated with Townes-Brocks syndrome.
TEST-2706 SALL4 Gene IVIC Syndrome Genetic Test This test detects pathogenic variants in the SALL4 gene associated with oculo‑oto‑radial syndrome.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SALL4 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "No fasting required"] Indications ["Suspected oculo-oto-radial syndrome", "Genetic counselling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 94411-0 ICD-10: Q87.0 Clinical summary This test detects pathogenic variants in the SALL4 gene associated with oculo‑oto‑radial syndrome.
TEST-6195 SARS2 Gene Genetic Test for Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis (HUPRA Syndrome) This test identifies pathogenic genetic variants in the SARS2 gene responsible for HUPRA syndrome.	Whole blood (3 mL EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SARS2 gene variants", "Single-nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["No dietary or medication restrictions needed", "Continue all prescribed treatments"] Indications ["Suspected HUPRA syndrome", "Family history of HUPRA syndrome", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 101264-6 ICD-10: Z15.89, E79.0, I27.0 Clinical summary This test identifies pathogenic genetic variants in the SARS2 gene responsible for HUPRA syndrome.
TEST-4778 SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test (NGS) This genetic test detects pathogenic variants in the SCP2 gene associated with leukoencephalopathy, dystonia, and motor neuropathy.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCP2 gene", "Coverage of coding and non-coding regions"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory", "No specific fasting or medication adjustments required unless advised by physician"] Indications ["Suspected SCP2 Gene Leukoencephalopathy", "Family history of SCP2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 93333-9 ICD-10: G93.8 Clinical summary This genetic test detects pathogenic variants in the SCP2 gene associated with leukoencephalopathy, dystonia, and motor neuropathy.
TEST-6096 SEC23B Gene CDAN2 (Congenital Dyserythropoietic Anemia Type II) Genetic Test This genetic test identifies pathogenic mutations in the SEC23B gene responsible for Congenital Dyserythropoietic Anemia Type II (CDA II).	Peripheral Blood (3-5 mL), Buccal Swab, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SEC23B gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 14 days)"] Indications ["Suspected Congenital Dyserythropoietic Anemia Type II", "Carrier screening for at-risk family members", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 101464-8 ICD-10: D56.4 Clinical summary This genetic test identifies pathogenic mutations in the SEC23B gene responsible for Congenital Dyserythropoietic Anemia Type II (CDA II).
TEST-4015 SERPINE1 Gene (Plasminogen Activator Inhibitor Type 1) Genetic Test This genetic test evaluates the SERPINE1 gene for pathogenic variants associated with altered PAI-1 function and increased risk of thrombotic events.	Peripheral Whole Blood (EDTA) or DNA FTA Card	21–28 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SERPINE1 gene", "PAI-1 protein function (indirectly)", "Fibrinolytic activity (indirectly)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any antithrombotic, anticoagulant, or hormone therapy"] Indications ["Personal history of venous or arterial thrombosis", "Family history of thrombophilia", "Evaluation of unexplained thrombotic events", "Risk stratification for thrombotic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 83019-5 ICD-10: Z15.89, D68.59, I82.401 Clinical summary This genetic test evaluates the SERPINE1 gene for pathogenic variants associated with altered PAI-1 function and increased risk of thrombotic events.
TEST-6143 SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test This genetic test identifies pathogenic variants in the SFXN4 gene associated with Combined Oxidative Phosphorylation Deficiency Type 18.	Peripheral blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SFXN4 gene sequence", "Pathogenic variants in SFXN4"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications"] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 18", "Family history of mitochondrial disorders", "Unexplained neurological or developmental issues"] Measurement technique Confirm with laboratory Codes LOINC: 48768-0 ICD-10: E88.49 Clinical summary This genetic test identifies pathogenic variants in the SFXN4 gene associated with Combined Oxidative Phosphorylation Deficiency Type 18.
TEST-4505 SKIV2L Gene Trichohepatoenteric Syndrome Type 2 Genetic Test This genetic test analyzes the SKIV2L gene to detect mutations associated with Trichohepatoenteric Syndrome Type 2 (THES2). It provides definitive molecular confirmation for this r...	Whole Blood (3–5 mL in EDTA tube), Extracted DNA, or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SKIV2L gene sequence", "Pathogenic variants in SKIV2L"] Parameters [] Preparation ["Genetic counseling session required prior to testing", "Fasting is not required"] Indications ["Clinical suspicion of Trichohepatoenteric Syndrome Type 2 (THES2)", "Carrier screening for THES2", "Family planning in families affected by THES2"] Measurement technique Confirm with laboratory Codes LOINC: 21651-4 ICD-10: Q87.8 Clinical summary This genetic test analyzes the SKIV2L gene to detect mutations associated with Trichohepatoenteric Syndrome Type 2 (THES2). It provides definitive molecular confirmation for this rare autosomal recessive disorder.
TEST-4572 SLC24A4 Genetic Test (Oculocutaneous Albinism Type 6 & Pigmentation Disorders) This diagnostic test evaluates the SLC24A4 gene for variants associated with oculocutaneous albinism type 6 and other pigmentation disorders.	Peripheral whole blood (EDTA tube) or capillary blood (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC24A4 gene sequence", "Pathogenic variants in SLC24A4"] Parameters [] Preparation ["No special dietary preparation required", "Inform phlebotomist of anticoagulant medications"] Indications ["Suspected oculocutaneous albinism type 6", "Family history of autosomal recessive pigmentation disorders", "Consanguineous couples planning marriage"] Measurement technique Confirm with laboratory Codes LOINC: 83435-2 ICD-10: E70.319, E70.39 Clinical summary This diagnostic test evaluates the SLC24A4 gene for variants associated with oculocutaneous albinism type 6 and other pigmentation disorders.
TEST-6221 SLC25A1 Gene Combined D-2- and L-2-Hydroxyglutaric Aciduria Genetic Test This genetic test detects pathogenic variants in the SLC25A1 gene to confirm a diagnosis of combined D-2- and L-2-hydroxyglutaric aciduria.	Peripheral Blood (EDTA) or Saliva (Oragene DNA kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A1 gene"] Parameters [] Preparation [] Indications ["Symptomatic patients with clinical suspicion of a neurometabolic disorder", "At-risk family members", "Carrier testing", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 81319-4 ICD-10: E72.89 Clinical summary This genetic test detects pathogenic variants in the SLC25A1 gene to confirm a diagnosis of combined D-2- and L-2-hydroxyglutaric aciduria.
TEST-6016 SLC25A3 Gene Genetic Test This test evaluates the SLC25A3 gene for pathogenic variants associated with mitochondrial phosphate carrier deficiency.	Whole Blood or DNA Sample (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A3 gene", "Mitochondrial phosphate carrier function"] Parameters [{"name": "Precision (Read Depth)", "reference_range": ">200x mean coverage"}] Preparation ["No fasting required", "No dietary restrictions", "No medication or supplement discontinuation without consulting a doctor"] Indications ["Diagnosis of mitochondrial phosphate carrier deficiency", "Carrier status testing", "Cascade screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94806-7 ICD-10: E88.49 Clinical summary This test evaluates the SLC25A3 gene for pathogenic variants associated with mitochondrial phosphate carrier deficiency.
TEST-3360 SLC25A38 Gene Pyridoxine-Refractory Sideroblastic Anemia Genetic Test This test identifies pathogenic variants within the SLC25A38 gene associated with autosomal recessive pyridoxine-refractory sideroblastic anemia.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the SLC25A38 gene", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab if on blood transfusion within 7 days"] Indications ["Suspected pyridoxine-refractory sideroblastic anemia", "Family history of pyridoxine-refractory sideroblastic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 81369-6 ICD-10: D64.0 Clinical summary This test identifies pathogenic variants within the SLC25A38 gene associated with autosomal recessive pyridoxine-refractory sideroblastic anemia.
TEST-5018 SLC29A3 Gene Histiocytosis‑Lymphadenopathy Plus Syndrome Genetic Test This genetic test evaluates the SLC29A3 gene for mutations associated with histiocytosis‑lymphadenopathy plus syndrome (H syndrome). It identifies pathogenic variants throughout th...	Whole Blood (peripheral) or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC29A3 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Fasting is not required", "Genetic counselling session and pedigree chart are mandatory before testing"] Indications ["Suspected histiocytosis‑lymphadenopathy plus syndrome (H syndrome)", "Family history of H syndrome", "Need for carrier screening in families with H syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 92726-2 ICD-10: D76.3 Clinical summary This genetic test evaluates the SLC29A3 gene for mutations associated with histiocytosis‑lymphadenopathy plus syndrome (H syndrome). It identifies pathogenic variants throughout the gene's coding sequence.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.